Search Results 221-230 of 17118 for monoclonal antibody

  1. Focus Areas - T Cell Engineering Laboratory - Mayo Clinic Research

    These include secondary modification of CAR-T cells and combination strategies with monoclonal antibodies, small molecules, peptides and other immunotherapeutic ...

  2. Linvoseltamab-gcpt (intravenous route) - Side effects & uses - Mayo Clinic

    These previous treatments include a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody. This medicine is available only ...

  3. Clinical trials - Oncology (Medical)

    ... monoclonal antibody, and compare them with clinical outcomes. Human Saliva as a Non-Invasive Tool for Cancer Diagnostics Using Surface-Enhanced Raman ...

  4. Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer - Mayo Clinic

    Monoclonal antibodies, such as atezolizumab, may block tumor growth in different ways by targeting certain cells. Drugs used in chemotherapy, such as ...

  5. 9-13 Q & A Podcast COVID-19 Update - Mayo Clinic News Network

    ... monoclonal antibody therapy in some cases. If you have this treatment, do you still develop your own antibodies and long-term protection? And does having ...

  6. A Randomized, Open-label Two-arm Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy after Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma - Mayo Clinic

    Primary mediastinal large B cell lymphoma is treated with a combination of chemotherapy and the monoclonal antibody rituximab (chemoimmunotherapy).

  7. Mayo Clinic Study Suggests Two is Better Than One When Battling Agressive Lymphoma

    When combined with a cocktail of chemotherapy drugs, two monoclonal antibodies, instead of one, appear to offer superior results in patients with diffuse ...

  8. Mayo Clinic innovations to ease burden of COVID-19 surge on hospitals

    Mayo Clinic is treating patients with COVID-19 who are at a high risk of hospitalization with bamlanivimab monoclonal antibodies at its infusion therapy centers ...

  9. A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (IMbrave152) (SKYSCRAPER-14) - Mayo Clinic

    The purpose of this study is to assess the efficacy and safety of tiragolumab, an anti-TIGIT monoclonal antibody, when administered in combination with ...

  10. Infliximab-dyyb (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

    This medicine is a monoclonal antibody that works on the immune system. This medicine is available only with your doctor's prescription. This product is ...